Reply: Comment on ‘Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal-antibody therapy for RAS wild-type metastatic colorectal cancer’

被引：0
|
作者：
Andrew Rowland
Mafalda M Dias
Michael D Wiese
Ganessan Kichenadasse
Ross A McKinnon
Christos S Karapetis
Michael J Sorich
机构：
[1] School of Medicine,Department of Clinical Pharmacology
[2] Flinders University,undefined
[3] Flinders Centre for Innovation in Cancer,undefined
[4] School of Medicine,undefined
[5] Flinders University,undefined
[6] School of Pharmacy and Medical Sciences,undefined
[7] University of South Australia,undefined
来源：
British Journal of Cancer | 2015年 / 113卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1635 / 1635
相关论文
共 50 条
  • [21] Hypomagnesemia and clinical benefits of anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer: a systematic review and meta-analysis
    Meng-Chiao Hsieh
    Chun-Feng Wu
    Chun-Wei Chen
    Chung-Sheng Shi
    Wen-Shih Huang
    Feng-Che Kuan
    Scientific Reports, 8
  • [22] First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer: A systematic review and meta-analysis
    Pietrantonio, Filippo
    Cremolini, Chiara
    Petrelli, Fausto
    Di Bartolomeo, Maria
    Loupakis, Fotios
    Maggi, Claudia
    Antoniotti, Carlotta
    de Braud, Filippo
    Falcone, Alfredo
    Iacovelli, Roberto
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 96 (01) : 156 - 166
  • [23] AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer
    Cardone, Claudia
    Blauensteiner, Bernadette
    Moreno-Viedma, Veronica
    Martini, Giulia
    Simeon, Vittorio
    Vitiello, Pietro P.
    Ciardiello, Davide
    Belli, Valentina
    Matrone, Nunzia
    Troiani, Teresa
    Morgillo, Floriana
    Marino, Federica Zito
    Dentice, Monica
    Nappi, Annarita
    Boccaccino, Alessandra
    Antoniotti, Carlotta
    Cremolini, Chiara
    Pietrantonio, Filippo
    Prager, Gerald W.
    Normanno, Nicola
    Maiello, Evaristo
    Argiles, Guillem
    Elez, Elena
    Signoriello, Giuseppe
    Franco, Renato
    Falcone, Alfredo
    Tabernero, Josep
    Sibilia, Maria
    Ciardiello, Fortunato
    Martinelli, Erika
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : 1 - 10
  • [24] Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma
    Lievre, Astrid
    Ouine, Berengere
    Canet, Jim
    Cartier, Aurelie
    Amar, Yael
    Cacheux, Wulfran
    Mariani, Odette
    Guimbaud, Rosine
    Selves, Janick
    Lecomte, Thierry
    Guyetant, Serge
    Bieche, Ivan
    Berger, Frederique
    de Koning, Leanne
    BRITISH JOURNAL OF CANCER, 2017, 117 (12) : 1819 - 1827
  • [25] Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma
    Astrid Lièvre
    Bérèngere Ouine
    Jim Canet
    Aurélie Cartier
    Yael Amar
    Wulfran Cacheux
    Odette Mariani
    Rosine Guimbaud
    Janick Selves
    Thierry Lecomte
    Serge Guyetant
    Ivan Bieche
    Frédérique Berger
    Leanne de Koning
    British Journal of Cancer, 2017, 117 : 1819 - 1827
  • [26] EGFR gene copy number as a predictive biomarker for resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer treatment:a meta-analysis
    Wei-Dong Shen
    Hong-Lin Chen
    Peng-Fei Liu
    ChineseJournalofCancerResearch, 2014, 26 (01) : 59 - 71
  • [27] Mucinous Histology Is Associated with Resistance to Anti-EGFR Therapy in Patients with Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer
    Wang, Chongkai
    Sandhu, Jaideep
    Fakih, Marwan
    ONCOLOGIST, 2022, 27 (02): : 104 - 109
  • [28] EGFR gene copy number as a predictive biomarker for resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer treatment: a meta-analysis
    Shen, Wei-Dong
    Chen, Hong-Lin
    Liu, Peng-Fei
    CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (01) : 59 - 71
  • [29] BRAF V600E Mutation as a Predictive Factor of Anti-EGFR Monoclonal Antibodies Therapeutic Effects in Metastatic Colorectal Cancer: a Meta-analysis
    Qi Wang
    Wei-guo Hu
    Qi-bin Song
    Jia Wei
    Chinese Medical Sciences Journal, 2014, 29 (04) : 197 - 203
  • [30] BRAF V600E and survival benefit of anti-EGFR monoclonal antibody (mAb) therapy for metastatic colorectal cancer (mCRC): A meta-analysis.
    Sorich, Michael
    Rowland, Andrew
    Dias, Mafalda
    McKinnon, Ross Allan
    Kichenadasse, Ganessan
    Wiese, Michael
    Karapetis, Christos Stelios
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345